Advertisement

Gastric Cancer

, 11:64 | Cite as

Locoregional control remains a critical issue in gastric cancer

  • Jolie Ringash
  • Stephen R. Smalley
  • Leonard L. Gunderson
Letter to the Editor
  • 216 Downloads

Keywords

Gastric Cancer Radiat Oncol Biol Phys Extensive Nodal Dissection Locoregional Failure Gastric Cancer Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hundahl SA, Peeters KCMJ, Kranenbarg EK, Hargrink H, Van de Velde CJH. Improved regional control and survival with “low Maruyama Index” surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial. Gastric Cancer 2007:10:84–86.PubMedCrossRefGoogle Scholar
  2. 2.
    Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:1–11.PubMedGoogle Scholar
  3. 3.
    Gunderson LL. Gastric cancer—patterns of relapse after surgical resection. Semin Radiat Oncol 2002;12:150–161.PubMedCrossRefGoogle Scholar
  4. 4.
    Wu C-W, Hsiung CA, Lo S-S, Hsieh M-C, Chen J-H, Li A F-Y, et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol 2006;7:309–315.PubMedCrossRefGoogle Scholar
  5. 5.
    Hartgrink HH, Van de Velde CJH, Putter H, Benenkamp JJ, Kranenbarg EK, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004;11:2069–2042.CrossRefGoogle Scholar
  6. 6.
    Kassam Z, Lockwood G, O’Brien C, Brierley J, Swallow C, Oza A, et al. Conformal radiotherapy in the adjuvant treatment of gastric cancer: review of 82 cases. Int J Radiat Oncol Biol Phys 2006;3:713–719.Google Scholar
  7. 7.
    Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T, for the Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278–286.PubMedCrossRefGoogle Scholar
  8. 8.
    Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;10:725–730.CrossRefGoogle Scholar
  9. 9.
    Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Coburn NG, Guller U, Baxter AN, Kiss A, Ringash J, Swallow C, Law CH. Adjuvant therapy for resected gastric cancer—rapid, yet incomplete adoption following the results of the Intergroup 0116 Trial. Int J Radiat Oncol Biol Phys 2007; in press; advance publication online October 1, 2007.Google Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2008

Authors and Affiliations

  • Jolie Ringash
    • 1
  • Stephen R. Smalley
    • 2
  • Leonard L. Gunderson
    • 3
  1. 1.The Princess Margaret HospitalTorontoCanada
  2. 2.Olathe Regional Oncology CenterOlatheUSA
  3. 3.Mayo Clinic Cancer Center — ArizonaScottsdaleUSA

Personalised recommendations